3Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med, 1996, 335(16): 1182-1189.
4Sharov V G, Sabbah H N, Shimoyama H, et al. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol, 1996,148:141-149.
5Misao J, Hayakawa Y, Ohno M, et al. Expression of bcl-2 protein, an inhibitor of apoptosis, and bax, an accelerator of apoptosis,in ventricular myocytes of human hearts with myocardial infarction. Circulation, 1996, 94(7):1506-1512.
6Nishigaki K, Minatoguchi S, Seishima M, et al. Plasma Fas ligand,an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. JACC,1997,29:1214-1219.
7Toyozaki T, Hiroe M, Saito T, et al. Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers. Am J Cardiol,1998,81:798-800.
8Yamaguchi S, Yamaoka M, Okuyama M, et al. Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure. Am J Cardiol, 1999,83:1500-1503.
10Smith CI, Rosenberg E, Reisher SR, et al. Sequence of rat surfactant protein A gene and functional mapping of its upstream region[J]. Am J Physiol, 1995,269(5 Pt 1) : L603-12.
